ICON Launches Device & Diagnostics Research Group

ICON plc has launched a new Medical Device & Diagnostics Research group combining the medical and regulatory device and diagnostic expertise of Aptiv Solutions, which ICON acquired in 2014, with ICON’s global clinical development and commercialization solutions. Services will support the full product lifecycle, including global clinical trial execution, health economics and pricing and market access solutions.
 
Vicki Anastasi, vice president, Medical Device & Diagnostic Research, will lead the Medical Device & Diagnostics Research group. The group is comprised of a team of project managers and clinical operations professionals as well as regulatory and strategic consultants.
 
“The device and diagnostic development model can differ significantly from that of pharmaceutical companies, both in complexity and time to market,” said Elizabeth Thiele, president, ICON Commercialization & Outcomes. “Operating under specific medical device SOPs and ISO certification, our new Medical Device & Diagnostics Research team has the expertise and flexibility to help manufacturers take time and cost from their development programs and maximize the value of their products.”